IP Library Assignment 046677/0476
Patent Assignment
Reel/Frame 046677/0476

Assignment of Assignor's Interest

Recorded: 2018-08-23 Pages: 12
Assignor
ESBATECH, A NOVARTIS COMPANY LLC
Executed: 2017-09-21
Assignee
CELL MEDICA SWITZERLAND AG
WAGISTRASSE 27, SCHLIEREN, 8952, SWITZERLAND
Covered Properties (5)
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 8,067,547 →
Application: 11/916,793 →
Publication: US 2009/0263382
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 8,389,693 →
Application: 13/245,420 →
Publication: US 2012/0064077
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 8,691,228 →
Application: 13/708,500 →
Publication: US 2013/0171143
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 9,315,572 →
Application: 14/185,783 →
Publication: US 2014/0171634
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 9,683,034 →
Application: 15/064,067 →
Publication: US 2016/0185850
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 2, 2008
From: BARBERIS, ALCIDE; URECH, DAVID M.; LICHTLEN, PETER; AUF DER MAUR, ADRIAN
To: ESBATECH AG
Reel/Frame 021027/0070 →
Change of Name Dec 11, 2009
From: ESBATECH AG
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT GMBH
Reel/Frame 023639/0314 →
Corrective Assignment to Correct the Legal Status of the Assignee as Llc, Not Gmbh Previously Recorded on Reel 023639 Frame 0314. Assignor(S) Hereby Confirms the Legal Status of the Assignee Is Esbatech, an Alcon Biomedical Research Unit Llc. Jan 4, 2010
From: ESBATECH AG
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 023720/0976 →
Assignment of Assignor's Interest Jan 21, 2021
From: CELL MEDICA SWITZERLAND AG
To: CELL MEDICA INC.
Reel/Frame 054988/0114 →
Security Interest Jul 7, 2021
From: CELL MEDICA, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 056782/0954 →
Assignment of Assignor's Interest Jul 18, 2022
From: CELL MEDICA INC.
To: CELL MEDICA, INC.
Reel/Frame 060529/0195 →